Table 2.
All (n=75) | Group 1: SNBx performed (n=35) | Group 2: LN staging not done (n=31) | Group 3: Metastatic disease at presentation (n=9) | P value | |
---|---|---|---|---|---|
| |||||
Gender | |||||
Male [no. (%)] | 49 (65) | 25 (71) | 16 (52) | 8 (89) | 0.07 |
| |||||
Age at diagnosis | |||||
(mean, yrs) | 53 | 54 | 53 | 50 | NS |
| |||||
Location of primary [no. (%)] | |||||
Trunk | 38 (51) | 19 (54) | 15 (48) | 4 (44) | NS |
Extremity | 31 (41) | 14 (40) | 15 (48) | 2 (22) | NS |
Head/Neck | 6 (8) | 2 (6) | 1 (3) | 3 (33) | 0.046 |
SNBx=Sentinel lymph node biopsy; NS= not significant